Recommended Hepatitis B Vaccination Schedule
The standard recommended schedule for Hepatitis B vaccination is a 3-dose series administered at 0,1, and 6 months for most individuals, with specific modifications for different age groups and special populations. 1
Standard Vaccination Schedules by Age Group
Infants
Infants born to HBsAg-negative mothers should receive:
- First dose: at birth (within 24 hours)
- Second dose: at 1-2 months of age
- Third dose: at 6 months of age 1
Infants born to HBsAg-positive mothers should receive:
- First dose: within 12 hours of birth (along with HBIG)
- Second dose: at 1-2 months of age
- Third dose: at 6 months of age 1
Children and Adolescents
Children who were not vaccinated as infants should follow:
- 3-dose schedule: 0,1, and 6 months, OR
- Alternative 2-dose schedule: adult formulation at 0 and 4-6 months (for specific age groups) 1
For children 5-10 years and adolescents 11-16 years, an alternative schedule of 0,12, and 24 months may be considered for those at low risk of immediate exposure 2, 3
Adults
- Standard adult schedule (≥18 years):
Special Populations
Chronic Kidney Disease and Hemodialysis Patients
For pre-dialysis CKD patients:
- Recombivax HB: 10 μg at 0,1, and 6 months, OR
- Engerix-B: 20 μg at 0,1, and 6 months 4
For dialysis-dependent patients:
Immunocompromised Adults
- Higher doses (40 μg) at 0,1, and 6 months
- Annual anti-HBs testing with booster doses when levels fall below 10 mIU/mL 1
Low Birth Weight Infants
- For infants with birth weight <2000g:
Post-Vaccination Testing
Post-vaccination serologic testing is recommended 1-2 months after completing the vaccination series for:
An anti-HBs level ≥10 mIU/mL indicates adequate protection 1, 4
Important Considerations and Pitfalls
Minimum intervals between doses must be maintained:
- Between 1st and 2nd doses: 4 weeks
- Between 2nd and 3rd doses: 8 weeks
- Between 1st and 3rd doses: 16 weeks 1
Delaying the birth dose beyond 12 hours for infants born to HBsAg-positive mothers significantly increases infection risk 1, 7
Using standard adult doses (20 μg) instead of higher doses (40 μg) in dialysis patients results in inadequate immune response 4
Failure to check post-vaccination antibody titers in high-risk groups may leave patients unprotected 4
While longer intervals between doses (such as the 0,12,24-month schedule) produce adequate protection, the standard 0,1,6-month schedule generally produces higher final antibody levels 3, 8